Tripyridyl carboxamide orexin receptor antagonists
US8349872B2 · kind B2 · utility
20Cited by
12References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 5, 2009 |
| Grant date | Jan 8, 2013 |
| Priority date | — |
| Expiry date | Nov 24, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to tripyridyl carboxamide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.